what just happened, page-43

i have to admit, ksx did a good job getting the placement through at 19cps.

personally i think things may go quiet now for several months and hence a lot of investors will lose interest but from the companies & long term investors point of view the money is in the bank now which will enable them to progress towards commercialisation.

for those willing to hold for up to 6 months by that time there could be a return of sentiment and if there are no hiccups along the way the asthma product should be edging quite close to commercialisation.

i would be interested in buying if the sp ever gets down to levels around 10 to 12cps which it may do during the quiet times, especially given the fact that reputable brokers are suggesting this current period of volotility and market correction has further to go.